MedPath

BOSTON MEDICAL CENTER

BOSTON MEDICAL CENTER logo
🇺🇸United States
Ownership
Private
Established
1996-01-01
Employees
1K
Market Cap
-
Website
http://www.bmc.org

Automated Assessment of Mental Health in the Workplace

Not Applicable
Completed
Conditions
Mental Disorders
First Posted Date
2005-08-25
Last Posted Date
2010-06-03
Lead Sponsor
Boston Medical Center
Target Recruit Count
150
Registration Number
NCT00134576
Locations
🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Phase 1
Terminated
Conditions
Leukemia
First Posted Date
2005-01-10
Last Posted Date
2013-01-04
Lead Sponsor
Boston Medical Center
Target Recruit Count
9
Registration Number
NCT00100971
Locations
🇺🇸

Cancer Research Center at Boston Medical Center, Boston, Massachusetts, United States

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

Phase 1
Completed
Conditions
Leukemia
Interventions
Drug: Deoxycoformycin
First Posted Date
2004-09-03
Last Posted Date
2012-06-13
Lead Sponsor
Boston Medical Center
Target Recruit Count
14
Registration Number
NCT00003005
Locations
🇺🇸

Johns Hopkins Oncology Center, Baltimore, Maryland, United States

🇺🇸

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States

🇺🇸

New England Medical Center Hospital, Boston, Massachusetts, United States

and more 10 locations

Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia

Phase 1
Completed
Conditions
Leukemia
First Posted Date
2004-05-04
Last Posted Date
2010-09-22
Lead Sponsor
Boston Medical Center
Registration Number
NCT00006097
Locations
🇺🇸

Boston Medical Center, Boston, Massachusetts, United States

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

Phase 2
Terminated
Conditions
Plasma Cell Neoplasm
Multiple Myeloma
Interventions
Biological: filgrastim
Procedure: autologous stem cell transplantation
Procedure: stem cell infusion
First Posted Date
2004-01-12
Last Posted Date
2017-01-27
Lead Sponsor
Boston Medical Center
Target Recruit Count
12
Registration Number
NCT00075608
Locations
🇺🇸

Boston University Cancer Research Center, Boston, Massachusetts, United States

Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis

Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
Procedure: autologous peripheral blood stem cell transplantation
First Posted Date
2004-01-12
Last Posted Date
2020-09-17
Lead Sponsor
Boston Medical Center
Target Recruit Count
62
Registration Number
NCT00075621
Locations
🇺🇸

Cancer Research Center at Boston Medical Center, Boston, Massachusetts, United States

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Phase 1
Completed
Conditions
Leukemia
Lymphoma
Precancerous Condition
Small Intestine Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-07-26
Lead Sponsor
Boston Medical Center
Registration Number
NCT00006340
Locations
🇩🇪

Medizinische Hochschule Hannover, Hannover, Germany

🇺🇸

Cancer Research Center at Boston Medical Center, Boston, Massachusetts, United States

🇮🇹

Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy

and more 3 locations

Nefazodone in the Treatment of Cocaine Dependence and Depression - 4

Phase 2
Completed
Conditions
Cocaine-Related Disorders
Substance-Related Disorders
Interventions
Behavioral: Psychosocial Treatment
First Posted Date
2001-04-18
Last Posted Date
2015-07-30
Lead Sponsor
Boston Medical Center
Target Recruit Count
69
Registration Number
NCT00015210
Locations
🇺🇸

Boston University, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath